NEWBURY PHARMACEUTICALS
P52StockF
€0.11 ▲ +19.69%
12 juin 2026
P
NEWBURY PHARMACEUTICALS
€0.11 ▲ +19.69%
12 juin 2026
P52StockF

01 / À propos

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Arberion
Loading market data